• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在欧洲背景下,从基因组研究中返回结果的实用清单。

A practical checklist for return of results from genomic research in the European context.

机构信息

Biomedical Ethics Research Group, Murdoch Children's Research Institute, Parkville, VIC, 3052, Australia.

University of Melbourne, Parkville, VIC, 3052, Australia.

出版信息

Eur J Hum Genet. 2023 Jun;31(6):687-695. doi: 10.1038/s41431-023-01328-6. Epub 2023 Mar 22.

DOI:10.1038/s41431-023-01328-6
PMID:36949262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10250331/
Abstract

An increasing number of European research projects return, or plan to return, individual genomic research results (IRR) to participants. While data access is a data subject's right under the General Data Protection Regulation (GDPR), and many legal and ethical guidelines allow or require participants to receive personal data generated in research, the practice of returning results is not straightforward and raises several practical and ethical issues. Existing guidelines focusing on return of IRR are mostly project-specific, only discuss which results to return, or were developed outside Europe. To address this gap, we analysed existing normative documents identified online using inductive content analysis. We used this analysis to develop a checklist of steps to assist European researchers considering whether to return IRR to participants. We then sought feedback on the checklist from an interdisciplinary panel of European experts (clinicians, clinical researchers, population-based researchers, biobank managers, ethicists, lawyers and policy makers) to refine the checklist. The checklist outlines seven major components researchers should consider when determining whether, and how, to return results to adult research participants: 1) Decide which results to return; 2) Develop a plan for return of results; 3) Obtain participant informed consent; 4) Collect and analyse data; 5) Confirm results; 6) Disclose research results; 7) Follow-up and monitor. Our checklist provides a clear outline of the steps European researchers can follow to develop ethical and sustainable result return pathways within their own research projects. Further legal analysis is required to ensure this checklist complies with relevant domestic laws.

摘要

越来越多的欧洲研究项目正在或计划向参与者返还个体基因组研究结果 (IRR)。虽然根据《通用数据保护条例》(GDPR),数据访问是数据主体的权利,并且许多法律和伦理准则允许或要求参与者接收在研究中生成的个人数据,但返还结果的实践并不简单,并且引发了一些实际和伦理问题。现有的重点关注返还 IRR 的准则大多是针对特定项目的,仅讨论了要返还哪些结果,或者是在欧洲以外制定的。为了解决这一差距,我们使用归纳内容分析法在线分析了现有的规范性文件。我们使用此分析结果制定了一份检查表,以协助考虑是否向参与者返还 IRR 的欧洲研究人员。然后,我们向一组来自欧洲的跨学科专家(临床医生、临床研究人员、基于人群的研究人员、生物库管理人员、伦理学家、律师和政策制定者)征求了对检查表的反馈意见,以完善检查表。该检查表概述了研究人员在确定是否以及如何向成年研究参与者返还结果时应考虑的七个主要部分:1) 决定返还哪些结果;2) 制定返还结果的计划;3) 获得参与者的知情同意;4) 收集和分析数据;5) 确认结果;6) 披露研究结果;7) 随访和监测。我们的检查表为欧洲研究人员提供了一个清晰的框架,用于在其自己的研究项目中制定符合伦理和可持续性的结果返还途径。需要进一步的法律分析以确保此检查表符合相关国内法律。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e661/10250331/bc303c897549/41431_2023_1328_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e661/10250331/bc303c897549/41431_2023_1328_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e661/10250331/bc303c897549/41431_2023_1328_Fig1_HTML.jpg

相似文献

1
A practical checklist for return of results from genomic research in the European context.在欧洲背景下,从基因组研究中返回结果的实用清单。
Eur J Hum Genet. 2023 Jun;31(6):687-695. doi: 10.1038/s41431-023-01328-6. Epub 2023 Mar 22.
2
Do patients and research subjects have a right to receive their genomic raw data? An ethical and legal analysis.患者和研究对象是否有权获得他们的基因组原始数据?一项伦理和法律分析。
BMC Med Ethics. 2020 Jan 16;21(1):7. doi: 10.1186/s12910-020-0446-y.
3
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
4
An Ethics Checklist for Digital Health Research in Psychiatry: Viewpoint.精神科数字健康研究的伦理学清单:观点。
J Med Internet Res. 2022 Feb 9;24(2):e31146. doi: 10.2196/31146.
5
Handling ethical, legal and social issues in birth cohort studies involving genetic research: responses from studies in six countries.处理涉及遗传研究的出生队列研究中的伦理、法律和社会问题:来自六个国家的研究的回应。
BMC Med Ethics. 2010 Mar 23;11:4. doi: 10.1186/1472-6939-11-4.
6
Finding Fault? Exploring Legal Duties to Return Incidental Findings in Genomic Research.吹毛求疵?探索基因组研究中返还偶发发现的法律义务。
Georgetown Law J. 2014;102:795-843.
7
Ethical considerations for biobanking and use of genomics data in Africa: a narrative review.非洲生物银行和基因组学数据使用的伦理考虑:叙事性综述。
BMC Med Ethics. 2023 Dec 5;24(1):108. doi: 10.1186/s12910-023-00985-y.
8
Perspectives and ethical considerations for return of genetics and genomics research results: a qualitative study of genomics researchers in Uganda.返回遗传学和基因组学研究结果的观点和伦理考虑:乌干达基因组学研究人员的定性研究。
BMC Med Ethics. 2021 Nov 19;22(1):154. doi: 10.1186/s12910-021-00724-1.
9
Returning individual research results in international direct-to-participant genomic research: results from a 31-country study.国际直接参与式基因组研究中返还个体研究结果:来自 31 个国家的研究结果。
Eur J Hum Genet. 2022 Oct;30(10):1132-1137. doi: 10.1038/s41431-022-01103-z. Epub 2022 Apr 28.
10
Ethical, legal, and social implications in research biobanking: A checklist for navigating complexity.研究生物样本库中的伦理、法律和社会问题:应对复杂性的清单。
Dev World Bioeth. 2024 Sep;24(3):139-150. doi: 10.1111/dewb.12411. Epub 2023 Jul 10.

引用本文的文献

1
Developing Requirements for a Standardized System to Return Individual Research Results Back to Study Participants: Narrative Review.制定将个体研究结果反馈给研究参与者的标准化系统的要求:叙述性综述。
Interact J Med Res. 2025 Aug 18;14:e65606. doi: 10.2196/65606.
2
Actionable genetic variants in 4,198 Scottish participants from the Orkney and Shetland founder populations and implementation of return of results.来自奥克尼群岛和设得兰群岛奠基人群的4198名苏格兰参与者中的可操作基因变异及结果反馈的实施
Am J Hum Genet. 2025 Apr 3;112(4):793-807. doi: 10.1016/j.ajhg.2025.02.018. Epub 2025 Mar 14.
3
Returning genetic risk information for hereditary cancers to participants in a population-based cohort study in Japan.

本文引用的文献

1
How Communicating Polygenic and Clinical Risk for Atherosclerotic Cardiovascular Disease Impacts Health Behavior: an Observational Follow-up Study.多基因和临床动脉粥样硬化性心血管疾病风险的沟通如何影响健康行为:一项观察性随访研究。
Circ Genom Precis Med. 2022 Apr;15(2):e003459. doi: 10.1161/CIRCGEN.121.003459. Epub 2022 Feb 7.
2
A Web Portal for Communicating Polygenic Risk Score Results for Health Care Use-The P5 Study.用于医疗保健用途的多基因风险评分结果交流网络门户——P5研究
Front Genet. 2021 Oct 29;12:763159. doi: 10.3389/fgene.2021.763159. eCollection 2021.
3
Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization.
向日本一项基于人群的队列研究的参与者反馈遗传性癌症的基因风险信息。
J Hum Genet. 2025 Mar;70(3):147-157. doi: 10.1038/s10038-024-01314-w. Epub 2025 Jan 17.
4
Global Perspectives on Returning Genetic Research Results in Parkinson Disease.帕金森病基因研究结果反馈的全球视角
Neurol Genet. 2024 Dec 5;10(6):e200213. doi: 10.1212/NXG.0000000000200213. eCollection 2024 Dec.
5
Nephrologists' Views on a Workflow for Returning Genetic Results to Research Participants.肾脏病专家对向研究参与者反馈基因检测结果工作流程的看法。
Kidney Int Rep. 2024 Sep 2;9(11):3278-3289. doi: 10.1016/j.ekir.2024.08.026. eCollection 2024 Nov.
6
Two founder variants account for over 90% of pathogenic BRCA alleles in the Orkney and Shetland Isles in Scotland.在苏格兰奥克尼群岛和设得兰群岛,有两个创始变体占致病 BRCA 等位基因的 90%以上。
Eur J Hum Genet. 2024 Dec;32(12):1624-1631. doi: 10.1038/s41431-024-01704-w. Epub 2024 Oct 22.
7
Assessment of the Needs of Nephrology Divisions to Implement Return of Clinically Significant Research Genetic Results: A Survey of Nephrotic Syndrome Study Network (NEPTUNE) Investigators.评估肾脏病科实施具有临床意义的研究性基因检测结果反馈的需求:肾病综合征研究网络(NEPTUNE)研究者调查
Glomerular Dis. 2023 Aug 21;3(1):178-188. doi: 10.1159/000533501. eCollection 2023 Jan-Dec.
8
The complex genomics of single gene disorders.单基因疾病的复杂基因组学。
Eur J Hum Genet. 2023 Jun;31(6):609-610. doi: 10.1038/s41431-023-01386-w.
研究生物库中可操作基因组结果的返还:分析有效性、临床实施和资源利用。
Am J Hum Genet. 2021 Dec 2;108(12):2224-2237. doi: 10.1016/j.ajhg.2021.10.005. Epub 2021 Nov 8.
4
Return of individual research results from genomic research: A systematic review of stakeholder perspectives.基因组研究中个体研究结果的返还:利益相关者观点的系统评价。
PLoS One. 2021 Nov 8;16(11):e0258646. doi: 10.1371/journal.pone.0258646. eCollection 2021.
5
My Research Results: a program to facilitate return of clinically actionable genomic research findings.我的研究成果:一个促进临床可操作的基因组研究结果回报的项目。
Eur J Hum Genet. 2022 Mar;30(3):363-366. doi: 10.1038/s41431-021-00973-z. Epub 2021 Oct 4.
6
Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).对《美国医学遗传学与基因组学学会(ACMG)关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.0列表:政策声明》的勘误
Genet Med. 2021 Aug;23(8):1582-1584. doi: 10.1038/s41436-021-01278-8.
7
Systematic Review of the Economic Evaluation of Returning Incidental Findings in Genomic Research.系统评价基因组研究中偶然发现结果回报的经济评估。
Front Public Health. 2021 Jul 1;9:697381. doi: 10.3389/fpubh.2021.697381. eCollection 2021.
8
An international policy on returning genomic research results.一项关于返还基因组研究成果的国际政策。
Genome Med. 2021 Jul 15;13(1):115. doi: 10.1186/s13073-021-00928-5.
9
Taking it to the bank: the ethical management of individual findings arising in secondary research.将其变为现实:二次研究中个体发现的伦理管理。
J Med Ethics. 2021 Oct;47(10):689-696. doi: 10.1136/medethics-2020-106941. Epub 2021 Jan 13.
10
Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants.基于基因型的遗传性乳腺癌和卵巢癌风险检测方法,以及向生物库参与者披露风险的效果。
Eur J Hum Genet. 2021 Mar;29(3):471-481. doi: 10.1038/s41431-020-00760-2. Epub 2020 Nov 23.